Enhanced breast cancer cell adherence to the lung endothelium via PAF acetylhydrolase inhibition: A potential mechanism for enhanced metastasis in smokers

American Journal of Physiology - Cell Physiology

Volumn 307, Issue 10, 2014, Pages C951-C956

  Kispert, Shannon E ^a   Marentette, John O ^a   McHowat, Jane ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cigarette smoke; Lung endothelium; Metastasis; Platelet activating factor

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; BROMOENOL LACTONE; CALCIUM; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CALCIUM INDEPENDENT PHOSPHOLIPASE A2BETA; CIGARETTE SMOKE; GINKGO BILOBA EXTRACT; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; UNCLASSIFIED DRUG; ENZYME INHIBITOR; SMOKE;

ARTICLE; BIOACCUMULATION; BREAST CANCER; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; ENZYME INACTIVATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNOBLOTTING; IN VITRO STUDY; INFLAMMATORY CELL; LUNG ENDOTHELIUM; LUNG METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; TUMOR INVASION; ADVERSE EFFECTS; ANTAGONISTS AND INHIBITORS; BREAST TUMOR; DRUG EFFECTS; ENDOTHELIUM CELL; ENZYMOLOGY; LUNG; MCF 7 CELL LINE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SMOKE;

GINKGO BILOBA;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; BREAST NEOPLASMS; CELL ADHESION; ENDOTHELIAL CELLS; ENZYME INHIBITORS; FEMALE; HUMANS; LUNG; MCF-7 CELLS; SMOKE; SMOKING;

EID: 84922481828     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00218.2014     Document Type: Article

References (32)

1. Anonymous. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Rockville, MD: Department of Health and Human Services, Public Health Service, Office of the Surgeon General, 2014.
2. Agaku IT, King BA, Dube SR. Current cigarette smoking among adults-United States, 2005-2012. MMWR Morb Mortal Wkly Rep 63: 29-34, 2014.
3. Anand P, Kunnumakkara AB, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 25: 2097-2116, 2008.
4. Bussolati B, Biancone L, Cassoni P, Russo S, Rola-Pleszczynski M, Montrucchio G, Camussi G. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Am J Pathol 157: 1713-1725, 2000.
5. Bussolino F, Arese M, Montrucchio G, Barra L, Primo L, Benelli R, Sanavio F, Aglietta M, Ghigo D, Rola-Pleszczynski MR. Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J Clin Invest 96: 940-952, 1995.
6. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 331: 1559-1564, 2011.
7. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572, 2002.
8. Dasgupta P, Rizwani W, Pillai S, Kinkade R, Kovacs M, Rastogi S, Banerjee S, Carless M, Kim E, Coppola D, Haura E, Chellappan S. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer 124: 36-45, 2009.
9. Im SY, Ko HM, Kim JW, Lee HK, Ha TY, Lee HB, Oh SJ, Bai S, Chung KC, Lee YB, Kang HS, Chun SB. Augmentation of tumor metastasis by platelet-activating factor. Cancer Res 56: 2662-2665, 1996.
10. Imaizumi T. Intravascular release of a platelet-activating factor-like lipid (PAF-LL) induced by cigarette smoking. Lipids 26: 1269-1273, 1991.
11. Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med 370: 60-68, 2014.
12. Johnson KC, Miller AB, Collishaw NE, Palmer JR, Hammond SK, Salmon AG, Cantor KP, Miller MD, Boyd NF, Millar J, Turcotte F. Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control 20: e2, 2011.
13. Kell PJ, Creer MH, Crown KN, Wirsig K, McHowat J. Inhibition of platelet-activating factor (PAF) acetylhydrolase by methyl arachidonyl fluorophosphonate potentiates PAF synthesis in thrombin-stimulated human coronary artery endothelial cells. J Pharmacol Exp Ther 307: 1163- 1170, 2003.
14. Lee T, Lenihan DJ, Malone B, Roddy LL, Wasserman SI. Increased biosynthesis of platelet-activating factor in activated human eosinophils. J Biol Chem 259: 5526-5530, 1984.
15. Levi R, Burke JA, Guo ZG, Hattori Y, Hoppens CM, McManus LM, Hanahan DJ, Pinckard RN. Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig. Circ Res 54: 117-124, 1984.
16. Luo J, Margolis KL, Wactawski-Wende J, Horn K, Messina C, Stefanick ML, Tindle HA, Tong E, Rohan TE. Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study. BMJ 342: d1016, 2011.
17. Montrucchio G, Alloatti G, Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 80: 1669-1699, 2000.
18. Montrucchio G, Sapino A, Bussolati B, Ghisolfi G, Rizea-Savu S, Silvestro L, Lupia E, Camussi G. Potential angiogenic role of plateletactivating factor in human breast cancer. Am J Pathol 153: 1589-1596, 1998.
19. Ninio E, Mencia-Huerta JM, Heymans F, Benveniste J. Biosynthesis of platelet-activating factor. I. Evidence for an acetyl-transferase activity in murine macrophages. Biochim Biophys Acta 710: 23-31, 1982.
20. Palmer JR, Rosenberg L. Cigarette smoking and the risk of breast cancer. Epidemiol Rev 15: 145-156, 1993.
21. Petrakis NL, Gruenke LD, Beelen TC, Castagnoli N, Craig JC. Nicotine in breast fluid of nonlactating women. Science 199: 303-305, 1978.
22. 2prevents inflammatory mediator production in pulmonary microvascular endothelium. Respir Physiol Neurobiol 165: 167-174, 2009.
23. 2β knockout mouse. Biochemistry 49: 5473-5481, 2010.
24. Sharma J, Young DM, Marentette JO, Rastogi P, Turk J, McHowat J. Lung endothelial cell platelet-activating factor production and inflammatory cell adherence are increased in response to cigarette smoke component exposure. Am J Physiol Lung Cell Mol Physiol 302: L47-L55, 2012.
25. Shopland DR. Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ Health Perspect 103 Suppl 8: 131-142, 1995.
26. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 63: 11-30, 2013.
27. Stein CJ, Colditz GA. Modifiable risk factors for cancer. Br J Cancer 90: 299-303, 2004.
28. Terry PD, Rohan TE. Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev 11: 953-971, 2002.
29. Thompson PA, DeMarini DM, Kadlubar FF, McClure GY, Brooks LR, Green BL, Fares MY, Stone A, Josephy PD, Ambrosone CB. Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells. Environ Mol Mutagen 39: 134-142, 2002.
30. Vinson SM, Rickard A, Ryerse JS, McHowat J. Neutrophil adherence to bladder microvascular endothelial cells following platelet-activating factor acetylhydrolase inhibition. J Pharmacol Exp Ther 314: 1241-1247, 2005.
31. Weigelt B, Peterse JL, van't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 5: 591-602, 2005.
32. Whatley RE, Zimmerman GA, McIntyre TM, Taylor R, Prescott SM. Production of platelet-activating factor by endothelial cells. Semin Thromb Hemost 13: 445-453, 1987.